FDA Extends Enforcement Deadline for Drug Supply Chain Security Act (DSCSA) Requirements | by: Sumeet Singh, Founder & Chairman | Article Posted: September 6, 2023 | Introduction The U.S. Food and Drug Administration (FDA) recently announced an extension on the...
Retail Pharmacy Headwinds: New Technology & Disruption The headwinds for retail pharmacy continue to grow as new technology and services are...
Two separate PBMs recently issued audits to an independent pharmacy because it was determined that the pharmacy was sourcing diverted test strips from an NABP DDA (fka VAWD®) Accredited facility.
Optum Rx’s requirement for their network pharmacies to only purchase prescription drug and diabetic testing supplies from Accredited wholesalers has caused significant disruption and controversy since its implementation in August 2016. The requirement spurred two separate lawsuits. The second, which continues in full force, has a recent amended complaint – and Pharma Solutions has unique insight into the lawsuit’s developments.
PBMs & Pharmacies, Episode V: States Strike Back The State of New York recently passed into law Assembly Bill A9507C, a seemingly mundane bill...
Over the last 20 years the pharmaceutical industry has completely changed due to consolidation– almost always to the detriment of the independent pharmacy’s bottom line.
PBMs Under Fire PBMs grew with conviction over the past decade but the tide has begun to turn: state and federal government, as well as PBM...
